Survival analysis suggested GC patients with high-regulated YTHDF1 (TMA1 cohort) or USP14 (TCGA cohort) expression exhibited worse overall survival as compared with patients having low YTHDF1 or USP14 expression (Figures 5G, 7F). This evidence concerns the gene YTHDF1 and gastric cancer.